“not significantly significant”

Wound complications The prevalence of wound complications was not significantly significant; nine studies saw a pooled estimated SMD of 0.49 (95% CI 0.22, 1.10; P = 0.08) (Figure 7 ).

A lower frequency of those with severely elevated baseline ICP were receiving antiretroviral therapy (ART) (40% compared to 50% or 51% in low-normal or moderately elevated baseline ICP groups), though this was not significantly significant ( P = .08).

PTH levels were not significantly significant after inclusion of compliant calcium/vitamin D3 users (logistic regression) (RR 3.2, CI 0.9–11.8, P = .08).

The percentage of patients with ≥25% reduction in IOP from baseline was higher in the LBN group as compared to the timolol group (31.0% vs 18.5%, P =0.007) and a higher percentage of subjects in the LBN group than in the timolol group had their IOP reduced to ≤ 18 mm Hg (17.7% vs 11.1%) though this was not significantly significant ( P =0.084). 19 In a pooled analysis of the APOLLO and LUNAR studies, LBN 0.024% provided greater IOP lowering compared to timolol 0.5% at 3 months of therapy and remained effective during the open-label extension phases of both studies.

Although some increased expression of CD44 and CD24 was observed in ALDH high populations relative to ALDH low populations, the difference was not significantly significant (p = 0.09).

The left ventricular end-diastolic dimension in the CPB group was larger than that in the no-CPB group, but this discrepancy was not significantly significant [66.00 (60.50, 67.75) vs. 57.00 (50.00, 66.00); P=0.101].

The frequency of RLS between DM and the control group was not significantly significant (p=0.107).

Mid-term outcome Although the estimated 1-year survival rate was higher in the pro-ECMO group than the non-ECMO group, this difference was not significantly significant (82.4% vs. 64.1%, log-rank P = 0.152, Figure 2 ).

The treatment‐related mortality with chemotherapy alone was not significantly significant than HSCT (7.5% [23/306] vs. 4.6% [11/240], p = 0.159).

Although a trend toward inferior OS times was observed in patients with CMV, the difference was not significantly significant (p=0.165) ( Figure 1 ).

HAEs Per Athlete Exposure On average, females sustained fewer HAEs per athlete exposure than male LECs, though this difference was not significantly significant (p = 0.169–0.432; Table 3 ).

Similarly, the overall estimated percent difference in opioid consumption from baseline after intervention between the two groups was not significantly significant ( p = 0.17). 3.3.

Within the median interval of 617 days between the first and last visit, the mean ± SD of VA logMAR change was 0.03 ± 0.22 for ATS-HOTV and −0.03 ± 0.24 for E-ETDRS, and their difference was not significantly significant ( P = 0.17).

Similarly, the risk difference of 0.0058 (95% CI: -0.003 - 0.014) was not significantly significant (P = 0.183).

Although the RF-EMF exposure from Wi-Fi was higher on weekdays compared with that for weekends, this difference was not significantly significant ( p = 0.194).

However, the difference between the two slopes was not significantly significant (z = 0.84, p = 0.2).

NS indicates difference between sAPPα immunodepleted and control groups were not significantly significant (t(4) = 1.49, p = 0.21).

Although the mean eCO was higher for children from smoking households by 17.6%, the finding was not significantly significant (t (98) = −2.3, p = 0.214).

It was considered that girls probably had fewer problems in this issue because it was clear that the general continence had a relation with maturation, thus girls completed maturation process earlier than boys.[ 25 ] In their study, Gümüs et al ., detected that the ratio of prevalence of EN was higher among boys than girls.[ 19 ] In the study of Gür et al ., the similar result was obtained.[ 2 ] However, even if it was not significantly significant, in this study the number of boys with EN was higher than girls (52.2%/47.8%) ( P = 0.244).

Approximately twice as many placebo recipients required early antibiotic treatment compared to the vaccinees (53.3% and 26.7%, respectively); however, this difference was not significantly significant, as the study was not powered for this ( p = 0.26) ( Table 1 ).

By the same test total zinc release from two sets of tablets having similar hardness but differing composition were also not significantly significant with P = 0.2634.

The difference was not significantly significant (p = 0.27, CI 0.50- 1.22 and RR 0.78).

Although the S100B levels in these subjects were reduced after 4 weeks, the difference was not significantly significant (p = 0.28).

More women in the placebo arm reported that they experienced fever; this difference was not significantly significant (7 (17.9%) vs. 4 (10%), p = 0.35).

Patients with BMI less than 40 who underwent surgery had fewer deaths (27 deaths [3.3%] in the surgery group vs 39 deaths [4.7%] in the control group), but the difference was not significantly significant (HR, 0.79 [95% CI, 0.48-1.29]; P = .35).